BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 19220530)

  • 1. Single versus double unrelated umbilical cord blood units for allogeneic transplantation in adults with advanced haematological malignancies: a retrospective comparison of outcomes.
    Bradstock K; Hertzberg M; Kerridge I; Svennilson J; George B; McGurgan M; Huang G; Antonenas V; Gottlieb D
    Intern Med J; 2009 Nov; 39(11):744-51. PubMed ID: 19220530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unrelated umbilical cord blood transplantation for adults with haematological malignancies: results from a single Australian centre.
    Bradstock KF; Hertzberg MS; Kerridge IH; Svennilson J; McGurgan M; Huang G; Antonenas V; Gottlieb DJ
    Intern Med J; 2006 Jun; 36(6):355-61. PubMed ID: 16732860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early hematopoietic recovery after single unit unrelated cord blood transplantation in adults supported by co-infusion of mobilized stem cells from a third party donor.
    Magro E; Regidor C; Cabrera R; Sanjuán I; Forès R; Garcia-Marco JA; Ruiz E; Gil S; Bautista G; Millán I; Madrigal A; Fernandez MN
    Haematologica; 2006 May; 91(5):640-8. PubMed ID: 16670070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Umbilical cord blood transplantation in adults: results of the prospective Cord Blood Transplantation (COBLT).
    Cornetta K; Laughlin M; Carter S; Wall D; Weinthal J; Delaney C; Wagner J; Sweetman R; McCarthy P; Chao N
    Biol Blood Marrow Transplant; 2005 Feb; 11(2):149-60. PubMed ID: 15682076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcomes of unrelated donor umbilical cord blood transplantation for 30 adults with hematological malignancies.
    Kobayashi K; Maeda Y; Hara Y; Nishie-Kataoka M; Nishimori H; Sugiyama H; Namba N; Kubonishi S; Niiya M; Shinagawa K; Ikeda K; Tanimoto M
    Anticancer Res; 2009 May; 29(5):1763-70. PubMed ID: 19443401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of unrelated umbilical cord blood transplantation for X-linked adrenoleukodystrophy.
    Beam D; Poe MD; Provenzale JM; Szabolcs P; Martin PL; Prasad V; Parikh S; Driscoll T; Mukundan S; Kurtzberg J; Escolar ML
    Biol Blood Marrow Transplant; 2007 Jun; 13(6):665-74. PubMed ID: 17531776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unrelated cord blood transplants in adults with hematologic malignancies.
    Arcese W; Rocha V; Labopin M; Sanz G; Iori AP; de Lima M; Sirvent A; Busca A; Asano S; Ionescu I; Wernet P; Gluckman E;
    Haematologica; 2006 Feb; 91(2):223-30. PubMed ID: 16461307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Umbilical cord blood cell transplantation from an unrelated donor: dual transplantation].
    Bautista G; Regidor C; Gonzalo-Daganzo R; Cabrera JR
    Methods Find Exp Clin Pharmacol; 2010 Dec; 32 Suppl A():47-51. PubMed ID: 21381288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre-engraftment syndrome after unrelated donor umbilical cord blood transplantation in patients with hematologic malignancies.
    Wang X; Liu H; Li L; Geng L; Ding K; Liu X; Tong J; Zhu W; Sun Z
    Eur J Haematol; 2012 Jan; 88(1):39-45. PubMed ID: 21933279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haematopoietic transplant potential of unrelated and related cord blood: the first six years of the EUROCORD/NETCORD Bank Germany.
    Kögler G; Somville T; Göbel U; Hakenberg P; Knipper A; Fischer J; Adams O; Krempe C; McKenzie C; Rüttgers H; Meier W; Bellmann O; Streng H; Ring A; Rosseck U; Rocha V; Wernet P
    Klin Padiatr; 1999; 211(4):224-32. PubMed ID: 10472555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myeloablative cord blood transplantation for adults with hematological malignancies using tacrolimus and short-term methotrexate for graft-versus-host disease prophylaxis: single-institution analysis.
    Yamada MF; Miyamura K; Fujiwara T; Kohata K; Okitsu Y; Ohguchi H; Yamamoto J; Yokoyama H; Tomiya Y; Ishizawa K; Kameoka J; Harigae H
    Transplant Proc; 2008 Dec; 40(10):3637-42. PubMed ID: 19100456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of postgrafting immunosuppressive regimens on nonrelapse mortality and survival after nonmyeloablative allogeneic hematopoietic stem cell transplant using the fludarabine and low-dose total-body irradiation 200-cGy.
    Koh LP; Chen CS; Tai BC; Hwang WY; Tan LK; Ng HY; Linn YC; Koh MB; Goh YT; Tan B; Lim S; Lee YM; Tan KW; Liu TC; Ng HJ; Loh YS; Mow BM; Tan DC; Tan PH
    Biol Blood Marrow Transplant; 2007 Jul; 13(7):790-805. PubMed ID: 17580257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Unrelated umbilical cord blood transplantation with TBI/Ara-c/CY non-ATG conditioning regimen for adults with hematologic malignancies].
    Sun ZM; Liu HL; Geng LQ; Zhou CY; Wang XB; Ding KY; Tong J; Zhu WB; Liu X; Wang ZY
    Zhonghua Yi Xue Za Zhi; 2012 Jun; 92(24):1660-4. PubMed ID: 22944153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allogeneic transplantation of G-CSF mobilized peripheral blood stem cells from unrelated donors: a retrospective analysis.
    Bornhäuser M; Theuser C; Soucek S; Hölig K; Klingebiel T; Blau W; Fauser A; Runde V; Schwinger W; Rutt C; Ehninger G
    Haematologica; 2000 Aug; 85(8):839-47. PubMed ID: 10942931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haematopoietic transplants combining a single unrelated cord blood unit and mobilized haematopoietic stem cells from an adult HLA-mismatched third party donor. Comparable results to transplants from HLA-identical related donors in adults with acute leukaemia and myelodysplastic syndromes.
    Sebrango A; Vicuña I; de Laiglesia A; Millán I; Bautista G; Martín-Donaire T; Regidor C; Cabrera R; Fernandez MN
    Best Pract Res Clin Haematol; 2010 Jun; 23(2):259-74. PubMed ID: 20837338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of human leucocyte antigen disparity and graft lymphocytes on allogeneic engraftment and survival after umbilical cord blood transplant in adults.
    van Heeckeren WJ; Fanning LR; Meyerson HJ; Fu P; Lazarus HM; Cooper BW; Tse WW; Kindwall-Keller TL; Jaroscak J; Finney MR; Fox RM; Solchaga L; Forster M; Creger RJ; Laughlin MJ
    Br J Haematol; 2007 Nov; 139(3):464-74. PubMed ID: 17910637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome following unrelated cord blood transplant in 136 patients with malignant and non-malignant diseases: a report from the Australian and New Zealand children's haematology and oncology group.
    Petterson TE; Gabriel M; Tiedemann K; Teague L; Shaw PJ; Baker D; Bolton-Jones R; Tapp H; Oswald C; Vowels MR; O'Brien TA
    Bone Marrow Transplant; 2009 Feb; 43(3):207-15. PubMed ID: 18806837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Costs of hematopoietic cell transplantation: comparison of umbilical cord blood and matched related donor transplantation and the impact of posttransplant complications.
    Majhail NS; Mothukuri JM; Brunstein CG; Weisdorf DJ
    Biol Blood Marrow Transplant; 2009 May; 15(5):564-73. PubMed ID: 19361748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unrelated cord blood transplantation after myeloablative conditioning in adults with ALL.
    Ooi J; Takahashi S; Tomonari A; Tsukada N; Konuma T; Kato S; Kasahara S; Sato A; Monma F; Nagamura F; Iseki T; Tojo A; Asano S
    Bone Marrow Transplant; 2009 Mar; 43(6):455-9. PubMed ID: 18955981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.